Emergent Biosolutions (EBS)
$7.49
0.43 (6.09%)
EBS Stock Quote Delayed 30 Minutes
7 Top Stocks Under $10: June 2024 Edition
While blue chip stocks are great, it's also a good idea to invest in top stocks under $10 to help improve your portfolio's diversification.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
392.48M
PE Ratio
-0.68
EPS
-10.95
Volume (Avg. Vol.)
4.67M
Day's Range
$7.24 - $8.29
52-Week Range
$1.42 - $8.29
Dividend & Yield
N/A (N/A)
EBS Stock Predictions, Articles, and Emergent Biosolutions News
Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?
Emergent BioSolutions stock is up on Thursday after the life sciences company posted a surprising profit and strong earnings in Q1 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!
EBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024
EBS stock results show that Emergent BioSolutions beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!
EBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023
EBS stock results show that Emergent BioSolutions missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?
Investors in Emergent Biosolutions and EBS stock certainly have a big catalyst to cheer today, as the company announced a new CEO.
EBS Stock Earnings: Emergent BioSolutions Misses EPS, Beats Revenue for Q3 2023
EBS stock results show that Emergent BioSolutions missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2023.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!
Emergent Biosciences (EBS) Stock Pops as FDA Approves Over-the-Counter Narcan
EBS stock is on the move as Emergent Biosciences expects its opioid emergency drug to be available soon without a prescription.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another breakdown of the biggest pre-market stock movers traders will want to know about on Thursday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with an overview of the biggest pre-market stock movers worth keeping an eye on Thursday morning!
Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health Emergency
Drugs and vaccines used against smallpox are seen as the first line of defense against the rising tide of monkeypox infections.
Monkeypox Stocks BVNRY, EBS, CMRX, SIGA Heat Up on U.S. Vaccine Stockpile
Stocks related to the treatment of monkeypox are heating up today on news that the U.S. is building a vaccine stockpile and will offer vaccine appointments to individuals who are at risk of contracting the virus.
